Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 38

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 38
---
 and short term investments. The Compensation Committee’s analysis of the level of achievement for each goal was subjective and the goals were considered in the aggregate, without a formulaic evaluation. In the aggregate, the Compensation Committee determined that overall, the corporate performance goals had been achieved at a level of one hundred fifteen percent (115%) for all Named Executive Officers. The 115% achievement was determined principally as a result of all goals being met and certain goals being exceeded. Corresponding payouts are noted in the table below. The bonus targets for the Named Executive Officers were not increased from 2023.

| Executive      |     | 2024 Base 
 Salary    |         |     | 2024   
 Target |    |   |     | 2024        
 Corporate   
 Performance 
 Achievement |     |   |     | 2024 Annual    
 Cash Incentive 
 Bonus          |         |
|:---------------|:----|:----------|--------:|:----|:-------|---:|:--|:----|:------------|----:|:--|:----|:---------------|--------:|
| Craig Collard  |     | $         | 669,500 |     |        | 75 | % |     |             | 115 | % |     | $              | 577,444 |
| Ira Duarte     |     | $         | 515,000 |     |        | 50 | % |     |             | 115 | % |     | $              | 296,125 |
| William Forbes |     | $         | 592,250 |     |        | 50 | % |     |             | 115 | % |     | $              | 340,544 |

Equity-Based Compensation Under our 2007 Plan, the Board (or a committee thereof, including the Compensation Committee) may grant stock options, shares of stock, restricted stock units, stock appreciation rights and performance awards. In granting these equity awards, the Board (or a committee thereof, including the Compensation Committee) may establish any conditions or restrictions it deems appropriate. The 2024 equity awards to our Named Executive Officers consist of a mix of time-based stock options, and time-based restricted stock unit awards. The time-based stock options vest over a four-year period, with 1/48 th of the covered shares vesting on each monthly anniversary of the grant date, subject to the respective grantee’s continued service through the applicable vesting date. The time-based restricted